RMFCX
Price
$55.64
Change
-$3.00 (-5.12%)
Updated
Dec 17 closing price
SVOAX
Price
$14.27
Change
-$2.21 (-13.41%)
Updated
Dec 17 closing price
Ad is loading...

RMFCX vs SVOAX

Header iconRMFCX vs SVOAX Comparison
Open Charts RMFCX vs SVOAXBanner chart's image
American Funds American Mutual R3
Price$55.64
Change-$3.00 (-5.12%)
VolumeN/A
CapitalizationN/A
SEI US Managed Volatility F (SIMT)
Price$14.27
Change-$2.21 (-13.41%)
VolumeN/A
CapitalizationN/A
RMFCX vs SVOAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RMFCX vs. SVOAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMFCX is a Buy and SVOAX is a Hold.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 104B vs. SVOAX (614M). RMFCX (1.69) and SVOAX (1.63) have matching dividends . RMFCX was incepted earlier than SVOAX: RMFCX (23 years) vs SVOAX (20 years). SVOAX is a more actively managed with annual turnover of: 49.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than SVOAX: RMFCX (250) vs SVOAX (100000). SVOAX annual gain was more profitable for investors over the last year : 19.97 vs. RMFCX (12.63). RMFCX return over 5 years is better than : 40.39 vs. SVOAX (-0.26).
RMFCXSVOAXRMFCX / SVOAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years20 years-
Gain YTD11.42318.74861%
Front LoadN/AN/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets104B614M16,938%
Annual Yield % from dividends1.691.63104%
Returns for 1 year12.6319.9763%
Returns for 3 years14.162.09678%
Returns for 5 years40.39-0.26-15,330%
Returns for 10 years61.8412.78484%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc